Serina Therapeutics (SER) Receivables - Other (2018 - 2024)
Serina Therapeutics (SER) posted Receivables - Other of -$163000.0 for Q1 2024, down 193.14% sequentially from $175000.0 in Q4 2023, and down 89.53% YoY from -$1.6 million in Q2 2023.
Serina Therapeutics (SER) Receivables - Other (2018 - 2024) Analysis & Trends
Serina Therapeutics has reported Receivables - Other for 4 years, with the latest figure at -$163000.0 in Q1 2024.
- Quarterly Receivables - Other fell 89.53% year-over-year to -$163000.0 in Q1 2024, while the trailing twelve-month figure through Jun 2024 was $673000.0 (changed N/A YoY) and the FY2023 annual result came in at $554000.0, changed N/A from the prior year.
- Receivables - Other retreated to -$163000.0 in Q1 2024 per SER's latest filing, from $175000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $661000.0 in Q3 2023 and troughed at -$196000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -163,000.00 |
| Mar 31, 2024 | -163,000.00 |
| Dec 31, 2023 | 175,000.00 |
| Dec 31, 2023 | 175,000.00 |
| Sep 30, 2023 | 661,000.00 |
| Sep 30, 2023 | 661,000.00 |
| Jun 30, 2023 | -196,000.00 |
| Jun 30, 2023 | -196,000.00 |
| Mar 31, 2023 | -86,000.00 |
| Mar 31, 2023 | -86,000.00 |
| Jun 30, 2019 | 78,000.00 |
| Jun 30, 2019 | 78,000.00 |
| Mar 31, 2019 | 16,000.00 |
| Mar 31, 2019 | 16,000.00 |
| Dec 31, 2018 | 78,000.00 |
| Dec 31, 2018 | 78,000.00 |